We are a technology based company “ TBC”, which was created as an spin-offs of The International Center for Biomedicine ICC. Its main aim is to develop and validate innovative high technology products, based in advanced scientific research (R&D) in the neuroscience field, generated by our scientific center.
In Neuroinnovation Ltd. we also develop technology of advanced medical impact in the fields of diagnostic, prevention and treatment for some neurodegenerative impairments. Our scientists developed the first approach for early detection of Alzheimer’s Disease (AD) based on biomarkers in the CSF, an innovative PET technology using lansoprazole as a probe, to detect at the preclinical stages the AD, and most recently a non-invasive biomarker in blood for detection of this disease and follow up of patents in advanced clinical trials. So, we are also aimed toward selling new inventions, patenting our good ideas that can be used in a technology transfer process. All this done under a solid scientific background, in order to approach science to society.
VisionTo be a world class company capable of promoting innovation, to develop technologies of high biomedical impact in the neuroscience field. Also to be able to create Chilean products that can prevent and do diagnostic and treatment for neurodegenerative impairments.
To bring sciences to people as a benefit for the whole society.